GOLDMAN SACHS GROUP INC - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 17 filers reported holding UNICYCIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$80,180
-34.7%
93,233
-2.8%
0.00%
Q2 2023$122,79295,9310.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,470,152$2,984,3310.33%
Nantahala Capital Management 3,470,541$2,984,6660.26%
BVF INC/IL 3,413,563$2,935,6640.08%
RA Capital Management 3,470,688$2,984,7920.06%
TANDEM CAPITAL MANAGEMENT CORP /ADV 31,000$26,6600.01%
Virtu Financial LLC 10,994$90.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 52,399$45,0630.00%
STATE STREET CORP 35,036$30,1310.00%
GOLDMAN SACHS GROUP INC 93,233$80,1800.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders